• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

距骨骨软骨损伤自体基质诱导软骨形成术后的长期结果:一项10年队列研究

Long-Term Results after Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: A 10-Year Cohort Study.

作者信息

Deiss Lukas, Walther Markus, Pfahl Kathrin, Hörterer Hubert, Mehlhorn Alexander, Röser Anke, Gottschalk Oliver

机构信息

Center for Foot and Ankle Surgery, Schön Klinik München Harlaching-FIFA Medical Centre of Excellence, Munich, Germany.

Ludwig Maximilian University Munich, Klinik für Orthopädie und Unfallchirurgie, Muskuloskelettales Zentrum München, Munich, Germany.

出版信息

Cartilage. 2024 Dec 12:19476035241301896. doi: 10.1177/19476035241301896.

DOI:10.1177/19476035241301896
PMID:39665329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11635787/
Abstract

OBJECTIVE

A gold standard surgical treatment for osteochondral lesions (OCLs) of the talus still needs to be established. Still, autologous matrix-induced chondrogenesis (AMIC) is a commonly applied 1-stage procedure that has achieved good short- and mid-term results. The present cohort study aimed to assess whether the long-term, 10-year results can confirm the previous findings.

DESIGN

All patients underwent an open AMIC procedure using a collagen type I/III bilayer matrix for a talar OCL. General demographic data, preoperative magnetic resonance imaging findings, intraoperative details, and German version of the Foot Function Index (FFI-D) scores preoperatively and at 1, 5, and 10 years as well as European Foot and Ankle Society (EFAS) and American Orthopedic Foot & Ankle Society (AOFAS) scores at 10 years after surgery were analyzed. The primary outcome variable was the procedure's longitudinal effect, and several variables' influence on the outcome was tested.

RESULTS

Of 47 consecutive patients, 18 (38%) were included. Of the 18 patients, 6 (33%) were female, and 12 (67%) were male, with a mean age of 39 ± 15 (range = 15-62) and an average body mass index (BMI) of 26 ± 5 (range = 20-38) kg/m². The mean defect size was 1.4 ± 0.9 (range = 0.2-4) cm². The FFI-D total score showed a significant decrease from preoperatively to 1 year postoperatively (56 ± 19 to 34 ± 27; = 0.001) with a further nonsignificant decrease to the 5-year (34 ± 27 to 21 ± 20; = 0.16) and 10-year follow-up (21 ± 20 to 15 ± 13; = 1.00). All the single items decreased significantly from preoperatively to the 5- and 10-year mark. Although not significant, most items improved from 5 to 10 years postoperatively. Age positively correlated with the preoperative, 5-year, and 10-year follow-up FFI-D total score.

CONCLUSIONS

AMIC, as a single-step surgical intervention, is a viable long-term treatment option. Patient selection regarding symptoms and findings is vital to achieve satisfying results.

摘要

目的

距骨骨软骨损伤(OCLs)的金标准手术治疗方法仍有待确立。不过,自体基质诱导软骨形成术(AMIC)是一种常用的一期手术,已取得良好的短期和中期效果。本队列研究旨在评估10年的长期结果是否能证实先前的研究结果。

设计

所有患者均接受了开放性AMIC手术,使用I/III型胶原双层基质治疗距骨OCL。分析了一般人口统计学数据、术前磁共振成像结果、术中细节,以及术前、术后1年、5年和10年的德文版足部功能指数(FFI-D)评分,以及术后10年的欧洲足踝协会(EFAS)和美国矫形足踝协会(AOFAS)评分。主要结局变量是该手术的纵向效果,并测试了几个变量对结局的影响。

结果

连续47例患者中,18例(38%)被纳入研究。18例患者中,女性6例(33%),男性12例(67%),平均年龄39±15岁(范围15 - 62岁),平均体重指数(BMI)为26±5(范围20 - 38)kg/m²。平均缺损面积为1.4±0.9(范围0.2 - 4)cm²。FFI-D总分从术前到术后1年显著下降(56±19降至34±27;P = 0.001),到5年时进一步非显著下降(34±27降至21±20;P = 0.16),10年随访时(21±20降至15±13;P = 1.00)。所有单项从术前到5年和10年时均显著下降。虽然不显著,但大多数项目在术后5年到10年有所改善。年龄与术前、5年和10年随访时的FFI-D总分呈正相关。

结论

AMIC作为一种单步手术干预,是一种可行的长期治疗选择。根据症状和检查结果进行患者选择对于取得满意结果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/11635787/22cfe8851210/10.1177_19476035241301896-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/11635787/8f4532ece9b5/10.1177_19476035241301896-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/11635787/c1ec6197665e/10.1177_19476035241301896-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/11635787/97eab4ef5acd/10.1177_19476035241301896-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/11635787/22cfe8851210/10.1177_19476035241301896-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/11635787/8f4532ece9b5/10.1177_19476035241301896-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/11635787/c1ec6197665e/10.1177_19476035241301896-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/11635787/97eab4ef5acd/10.1177_19476035241301896-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/299a/11635787/22cfe8851210/10.1177_19476035241301896-fig4.jpg

相似文献

1
Long-Term Results after Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: A 10-Year Cohort Study.距骨骨软骨损伤自体基质诱导软骨形成术后的长期结果:一项10年队列研究
Cartilage. 2024 Dec 12:19476035241301896. doi: 10.1177/19476035241301896.
2
Functional Medium-Term Results After Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: A 5-Year Prospective Cohort Study.距骨骨软骨损伤自体基质诱导软骨形成术后的中期功能结果:一项5年前瞻性队列研究
J Foot Ankle Surg. 2017 Sep-Oct;56(5):930-936. doi: 10.1053/j.jfas.2017.05.002. Epub 2017 Jun 21.
3
Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: A Clinical and Radiological 2- to 8-Year Follow-up Study.自体软骨细胞-载体复合物移植治疗距骨骨软骨损伤:2-8 年临床及放射学随访研究
Am J Sports Med. 2019 Jun;47(7):1679-1686. doi: 10.1177/0363546519841574. Epub 2019 May 14.
4
Reconstruction of osteochondral lesions of the talus with autologous spongiosa grafts and autologous matrix-induced chondrogenesis.自体松质骨移植物和自体基质诱导软骨再生术治疗距骨骨软骨病变。
Am J Sports Med. 2013 Mar;41(3):519-27. doi: 10.1177/0363546513476671. Epub 2013 Feb 7.
5
Clinical outcome and T2 assessment following autologous matrix-induced chondrogenesis in osteochondral lesions of the talus.距骨骨软骨损伤自体基质诱导软骨形成后的临床结果及T2评估
Int Orthop. 2016 Jan;40(1):65-71. doi: 10.1007/s00264-015-2988-z. Epub 2015 Sep 8.
6
Autologous matrix induced chondrogenesis (AMIC) as revision procedure for failed AMIC in recurrent symptomatic osteochondral defects of the talus.自体诱导软骨生成术(AMIC)作为复发性症状性距骨骨软骨缺损中 AMIC 失败的翻修手术。
Sci Rep. 2022 Sep 28;12(1):16244. doi: 10.1038/s41598-022-20641-6.
7
All-arthroscopic AMIC (AT-AMIC) technique with autologous bone graft for talar osteochondral defects: clinical and radiological results.关节镜下自体骨移植 AMIC(AT-AMIC)技术治疗距骨骨软骨缺损:临床与影像学结果。
Knee Surg Sports Traumatol Arthrosc. 2018 Mar;26(3):875-881. doi: 10.1007/s00167-016-4318-4. Epub 2016 Sep 12.
8
AMIC for traumatic focal osteochondral defect of the talar shoulder: a 5 years follow-up prospective cohort study.距骨穹隆外伤性局灶性骨软骨缺损的 AMIC 治疗:一项 5 年随访前瞻性队列研究。
BMC Musculoskelet Disord. 2021 Jul 24;22(1):638. doi: 10.1186/s12891-021-04506-z.
9
Is there clinical evidence to support autologous matrix-induced chondrogenesis (AMIC) for chondral defects in the talus? A systematic review and meta-analysis.自体诱导软骨生成术(AMIC)治疗距骨软骨缺损的临床疗效如何?系统评价和荟萃分析。
Foot Ankle Surg. 2021 Apr;27(3):236-245. doi: 10.1016/j.fas.2020.07.011. Epub 2020 Aug 16.
10
Combining Microfractures, Autologous Bone Graft, and Autologous Matrix-Induced Chondrogenesis for the Treatment of Juvenile Osteochondral Talar Lesions.联合微骨折、自体骨移植和自体基质诱导软骨生成治疗青少年距骨骨软骨损伤
Foot Ankle Int. 2017 May;38(5):485-495. doi: 10.1177/1071100716687367. Epub 2017 Jan 11.

本文引用的文献

1
Significant Clinical Improvement After Arthroscopic Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: A 5-Year Follow-Up.距骨骨软骨损伤关节镜下自体基质诱导软骨形成术后的显著临床改善:5年随访
Cartilage. 2024 Mar 30:19476035241240341. doi: 10.1177/19476035241240341.
2
Etiology, Classification, Diagnostics, and Conservative Management of Osteochondral Lesions of the Talus. 2023 Recommendations of the Working Group "Clinical Tissue Regeneration" of the German Society of Orthopedics and Traumatology.距骨骨软骨损伤的病因学、分类、诊断及保守治疗。德国矫形外科学会“临床组织再生”工作组 2023 年的建议。
Cartilage. 2023 Sep;14(3):292-304. doi: 10.1177/19476035231161806. Epub 2023 Apr 21.
3
Autologous Matrix-Induced Chondrogenesis (AMIC) for Osteochondral Defects of the Talus: A Systematic Review.
自体基质诱导软骨形成术(AMIC)治疗距骨骨软骨损伤:一项系统评价
Life (Basel). 2022 Oct 29;12(11):1738. doi: 10.3390/life12111738.
4
Correlation between EFAS- and MOCART score and clinical outcome after AMIC-procedure for osteochondral lesion of the talus.距骨骨软骨损伤行关节镜下微骨折术(AMIC)后,EFAS评分与MOCART评分之间的相关性及临床结果
Arch Orthop Trauma Surg. 2023 Jun;143(6):2895-2900. doi: 10.1007/s00402-022-04474-6. Epub 2022 May 21.
5
Allograft Versus Autograft Osteochondral Transplant for Chondral Defects of the Talus: Systematic Review and Meta-analysis.异体骨软骨移植与自体骨软骨移植治疗距骨软骨缺损:系统评价和荟萃分析。
Am J Sports Med. 2022 Oct;50(12):3447-3455. doi: 10.1177/03635465211037349. Epub 2021 Sep 23.
6
Matrix-induced autologous chondrocyte implantation versus autologous matrix-induced chondrogenesis for chondral defects of the talus: a systematic review.基质诱导自体软骨细胞移植与自体基质诱导软骨生成治疗距骨软骨缺损的系统评价。
Br Med Bull. 2021 Jun 10;138(1):144-154. doi: 10.1093/bmb/ldab008.
7
AMIC for Focal Osteochondral Defect of the Talar Shoulder.距骨肩部局灶性骨软骨缺损的自体基质诱导软骨形成术
Life (Basel). 2020 Dec 5;10(12):328. doi: 10.3390/life10120328.
8
Is there clinical evidence to support autologous matrix-induced chondrogenesis (AMIC) for chondral defects in the talus? A systematic review and meta-analysis.自体诱导软骨生成术(AMIC)治疗距骨软骨缺损的临床疗效如何?系统评价和荟萃分析。
Foot Ankle Surg. 2021 Apr;27(3):236-245. doi: 10.1016/j.fas.2020.07.011. Epub 2020 Aug 16.
9
Stable clinical long term results after AMIC in the aligned knee.AMIC 治疗后膝关节对线良好的稳定临床长期结果。
Arch Orthop Trauma Surg. 2021 Nov;141(11):1845-1854. doi: 10.1007/s00402-020-03564-7. Epub 2020 Aug 13.
10
The Role of Magnetic Resonance Imaging in Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: Analyzing MOCART 1 and 2.0.磁共振成像在自体骨髓基质诱导软骨生成治疗距骨骨软骨病变中的作用:分析 MOCART1 和 2.0。
Cartilage. 2021 Dec;13(1_suppl):639S-645S. doi: 10.1177/1947603520946382. Epub 2020 Aug 1.